{{Rsnum
|rsid=9349407
|Gene=CD2AP
|Chromosome=6
|position=47485642
|Orientation=plus
|GMAF=0.1905
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=CD2AP
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 8.1 | 38.7 | 53.2
| HCB | 1.5 | 22.4 | 76.1
| JPT | 2.7 | 18.6 | 78.8
| YRI | 1.4 | 23.6 | 75.0
| ASW | 0.0 | 35.1 | 64.9
| CHB | 1.5 | 22.4 | 76.1
| CHD | 0.9 | 23.9 | 75.2
| GIH | 2.0 | 42.9 | 55.1
| LWK | 3.7 | 30.3 | 66.1
| MEX | 0.0 | 0.0 | 0.0
| MKK | 2.6 | 25.2 | 72.2
| TSI | 6.9 | 37.6 | 55.4
| HapMapRevision=28
}}[[Alzheimer's disease]] associated, based on large 2011 study {{doi|10.1038/ng.801}}

{{PMID Auto
|PMID=21460841
|Title=Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|OA=1
}}

{{PMID Auto
|PMID=23836404
|Title=Genetic Susceptibility for Alzheimer Disease Neuritic Plaque Pathology
}}

{{PMID Auto
|PMID=25092125
|Title=Analyzing 54,936 Samples Supports the Association Between CD2AP rs9349407 Polymorphism and Alzheimer's Disease Susceptibility
}}
{{on chip | Affy GenomeWide 6}}